Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23477833

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 Apr
First author
Schwartz GK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Apr;14(4):276-7. doi: 10.1016/S1470-2045(13)70089-5.
    note
    Source null
    related pmid
    23477834
    relationship
    Comment in

Authors and identifiers

  1. name
    Schwartz GK
    type
    Author
  2. name
    Tap WD
    type
    Author
  3. name
    Qin LX
    type
    Author
  4. name
    Livingston MB
    type
    Author
  5. name
    Undevia SD
    type
    Author
  6. name
    Chmielowski B
    type
    Author
  7. name
    Agulnik M
    type
    Author
  8. name
    Schuetze SM
    type
    Author
  9. name
    Reed DR
    type
    Author
  10. name
    Okuno SH
    type
    Author
  11. name
    Ludwig JA
    type
    Author
  12. name
    Keedy V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Schwartz GK
    type
    Author
  2. name
    Tap WD
    type
    Author
  3. name
    Qin LX
    type
    Author
  4. name
    Livingston MB
    type
    Author
  5. name
    Undevia SD
    type
    Author
  6. name
    Chmielowski B
    type
    Author
  7. name
    Agulnik M
    type
    Author
  8. name
    Schuetze SM
    type
    Author
  9. name
    Reed DR
    type
    Author
  10. name
    Okuno SH
    type
    Author
  11. name
    Ludwig JA
    type
    Author
  12. name
    Keedy V
    type
    Author
bibliography ids
  1. nci-bib-aedd16939f019200259e7fce
book metadata
content sha256
f88ad9e5036e29e9fbdf86c7299d87673d5d59c3e09b508e4e6d5278db161ce9
document type
citation
dois
  1. 10.1016/S1470-2045(13)70049-4
electronic publication date
display
2013 Mar 8
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23477833
immutable id
pubmed:23477833@f88ad9e5036e29e9fbdf86c7299d87673d5d59c3e09b508e4e6d5278db161ce9
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
371-82
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Apr;14(4):276-7. doi: 10.1016/S1470-2045(13)70089-5.
    note
    Source null
    related pmid
    23477834
    relationship
    Comment in
outcomes validated
false
pmid
23477833
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
c965c17fdaddae926213ce250bc7495a6452cb96ed993ed6ba9649d508d1bb11
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Apr
precision
month
year
2013
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23477833/
title
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.

Preserved source evidence · Not medical advice